| pubmed-article:1433369 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1433369 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:1433369 | lifeskim:mentions | umls-concept:C0031332 | lld:lifeskim |
| pubmed-article:1433369 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:1433369 | lifeskim:mentions | umls-concept:C0165187 | lld:lifeskim |
| pubmed-article:1433369 | pubmed:issue | 23 | lld:pubmed |
| pubmed-article:1433369 | pubmed:dateCreated | 1992-12-18 | lld:pubmed |
| pubmed-article:1433369 | pubmed:abstractText | Sulofenur is a diarylsulfonylurea with demonstrated antitumor activity in patients with advanced epithelial ovarian cancer refractory to standard chemotherapy. The dose-limiting toxic effects observed in phase I clinical trials have been anemia and methemoglobinemia, resulting in cyanosis. | lld:pubmed |
| pubmed-article:1433369 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1433369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1433369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1433369 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1433369 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1433369 | pubmed:issn | 0027-8874 | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:SeitzDD | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:AlbertsD SDS | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:HamiltonMM | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:TaylorC WCW | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:GrindeyG BGB | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:PengY MYM | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:MatznerMM | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:RoeD JDJ | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:PleziaP MPM | lld:pubmed |
| pubmed-article:1433369 | pubmed:author | pubmed-author:McCloskeyT... | lld:pubmed |
| pubmed-article:1433369 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1433369 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:1433369 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:1433369 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1433369 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1433369 | pubmed:pagination | 1798-802 | lld:pubmed |
| pubmed-article:1433369 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:meshHeading | pubmed-meshheading:1433369-... | lld:pubmed |
| pubmed-article:1433369 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1433369 | pubmed:articleTitle | Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer. | lld:pubmed |
| pubmed-article:1433369 | pubmed:affiliation | Department of Internal Medicine, Arizona Cancer Center, University of Arizona College of Medicine, Tucson 85724. | lld:pubmed |
| pubmed-article:1433369 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1433369 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1433369 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1433369 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:1433369 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
